Side-by-side financials for BCAB and BIIB. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BCAB | BIIB |
|---|---|---|
| Market cap | - | $29.52 B |
| US-listed rank | - | #472 |
| Revenue (latest FY) | $300.00K | $9.89B |
| Net income (latest FY) | -$59.61M | $1.29B |
| Net margin | -19869.0% | 13.1% |
| P/E (trailing FY) | - | 22.8 |
| SEC filings | 490 | 2,690 |
Full pages: BioAtla, Inc. and BIOGEN INC., or browse the full rankings.